RE
Reem El‐Shenawy

Publications (7)

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt
Article scientifique · 2025
Correction: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia
Article scientifique · 2024
Correction: Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Article scientifique · 2024
Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals
Article scientifique · 2024
Polyphenol Content, Antioxidant, Cytotoxic, and Genotoxic Activities of Bombax ceiba Flowers in Liver Cancer Cells Huh7
Article scientifique · 2022
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice
Article scientifique · 2019
Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents
Article scientifique · 2017

Domaines principaux

Sciences de la santé6 Sciences de la vie et biotechnologies1

Statistiques

Consultations6
Téléchargements0